Yes, absolutely.
We have to realize that Health Canada will authorize a vaccine or a medication, and it's not the first time the clinical guidelines will differ from what has been authorized. In this particular case, Health Canada deemed the vaccine was safe and efficacious enough to be used in all age groups, which is its decision. What we had in terms of data did not make us comfortable enough at that point to allow for the use of AstraZeneca in those aged 65-plus. I realize that since then real-world evidence has emerged. As I said, we met yesterday to review that data.
It's possible that at points in time we will differ in opinion, but I would ask the members of this committee if they think it would be preferable that we would have erred with Health Canada, even though in our opinion we weren't ready to make that recommendation.
We make recommendations based on multiple issues, including looking at other vaccines that are available. As I said, we had two mRNA vaccines that were highly efficacious in those aged 65-plus, and our mathematical modelling showed us that what we had proposed was a recommendation that was completely sane, and that's what the committee was comfortable with.